Two Deaths Raise Concerns Over Plasma Donation Safety at Canadian Clinics
Two individuals have died in Canada following plasma donations at Grifols-operated clinics, raising serious concerns about the company’s record-keeping, donor screening, and equipment maintenance practices. These fatalities have prompted ongoing investigations by Health Canada, although the company maintains no correlation exists between the donations and the deaths. Federal inspection reports have revealed multiple deficiencies at Grifols facilities, including issues with accurately assessing donor suitability and maintaining critical equipment, echoing past concerns about the safety of Canada’s blood product system. The situation highlights broader debates about the role of private companies in Canada’s blood and plasma collection, particularly in light of historical scandals and the country’s reliance on imported plasma.
John Q. Hosedrinker